[China Jo-Jo Drugstores Reports Second Quarter Fiscal Year 2016 Financial Results - Q2'16 Revenue up 22.4% y-o-y; - Strategic revenue mix continues to rebalance as online pharmacy revenues grew 122.4% y-o-y; - Official Branded Online Website Sales Grew 406.2% y-o-y HANGZHOU, China, Nov. 12, 2015 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a] []
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer EX-32.1 4 f10q0615ex32i_chinajojodrug.htm CERTIFICATION] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0615ex32ii_chinajojodrug.htm CERTIFICATION]
[] [CERTIFICATION I, Lei Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Ming Zhao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer EX-32.1 4 f10q0615ex32i_chinajojodrug.htm CERTIFICATION] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ming Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 f10q0615ex32ii_chinajojodrug.htm CERTIFICATION]
[China Jo-Jo Drugstores Announces First Quarter Financial Results for Fiscal Year 2016 HANGZHOU, China, Aug. 12, 2015 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading China-based retail and wholesale distributor of pharmaceutical and health care products through its own online and retail pharmacies, today announced financial results for the first quarter ended] []
[China Jo-Jo Drugstores Announces First Quarter Financial Results for Fiscal Year 2016 HANGZHOU, China, Aug. 12, 2015 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) (the "Company" or "China Jo-Jo"), a leading China-based retail and wholesale distributor of pharmaceutical and health care products through its own online and retail pharmacies, today announced financial results for the first quarter ended] []
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the liabilities of]
[reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the liabilities of]
[China Jo-Jo Drugstores Announces the Closing of a Registered Direct shall be initially exercisable six months following issuance and expire five years from the date on which they are initially exercisable. The Company received net proceeds from the offering in the amount of approximately $2.7 million, after deducting the placement agency fees and the estimated offering expenses payable by the] []
[China Jo-Jo Drugstores Announces the Closing of a Registered Direct shall be initially exercisable six months following issuance and expire five years from the date on which they are initially exercisable. The Company received net proceeds from the offering in the amount of approximately $2.7 million, after deducting the placement agency fees and the estimated offering expenses payable by the] []
